Researchers analyzed the efficacy of rifaximin for relieving IBS-D symptoms, specifically abdominal pain, bloating, and bowel movement urgency.
Digestive Disease Week 2022 News
Researchers investigated whether adherence to specific diets were associated with changes in liver fat or incident nonalcoholic fatty liver disease.
Researchers assessed the benefit of early vs late endoscopic retrograde cholangiopancreatography in hospitalized patients with acute biliary pancreatitis.
Researchers investigated the relationship between eosinophilic esophagitis at the time of diagnosis and disease severity, and the change in disease before and after treatment.
A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.
Presenting at DDW 2022, researchers identified the risk factors associated with the development of early-onset advanced colorectal neoplasia in young adults.
Normalization of 2 factors can foretell the potential for recurrence in patients who were in remission, according to a report.
Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
Researchers developed and assessed logistic prediction models for the detection of advanced neoplasia (AN) and colorectal cancer (CRC).
Researchers evaluated liver test abnormalities in patients hospitalized with COVID-19 and assessed cytokine levels in individuals with vs without abnormal test results.